Source: Annual Congress 2004 - Thrombo-embolic diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Jiménez, G. Díaz, E. Pérez-Rodríguez, S. García-Rull, R. Vidal, A. Sueiro (Madrid, Spain). Fixed or weight-adjusted dosis of enoxaparin as prophylaxis for venous thromboembolism in acutelly ill medical patients. Eur Respir J 2004; 24: Suppl. 48, 1786

Member's Comments

No comment yet.

Related content which might interest you: Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Incidence of venous thromboembolism 8-weeks post discharge in hospitalised medical patients not receiving thrombo-prophylaxis Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Efficiency of r-TPA therapy in major venous thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 83s Year: 2007 Complications of anticoagulant therapy in patients with pulmonary thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 604s Year: 2007 Enoxaparin versus unfractionated heparin in acute pulmonary thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 237s Year: 2002 Treatment of VTE during pregnancy with a once-daily regimen of LMWH Source: Annual Congress 2007 - Acute and chronic pulmonary embolism Year: 2007 Direct oral anticoagulants and low-molecular weight heparin for primary prevention of venous thromboembolism in cancer patients: a meta-analysis Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism Year: 2020 Effectiveness of anticoagulation with unfractionated heparin for acute pulmonary embolism Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 Effectiveness of thrombolytic therapy in pulmonary thromboembolism Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007 Direct oral anticoagulants and venous thromboembolism Source: Eur Respir Rev 2016; 25: 295-302 Year: 2016 Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Source: Eur Respir J 2016; 48: 1369-1376 Year: 2016 Comparison of two regimens of oral anticoagulation in pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 632s Year: 2006 Rivaroxaban versus standard anticoagulation for the treatment of pulmonary embolism: a real-life study Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment Year: 2019 Venous thromboembolism prophylaxis in hospitalised patients with pneumonia: a prospective survey Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009 Compliance with venous thromboembolic (VTE) risk assessment and prophylaxis in medical inpatients at an English DGH Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Venous thromboembolism (VTE) prophylaxis in acute medical admissions to a university hospital Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009 A single centre experience of low dose direct oral anticoagulants (DOAC) after unprovoked venous thromboembolism (VTE) Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 Sticker reminders improve VTE prophylaxis appropriatness in hospitalized patients Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Efficacy and safety of extended antithrombotic prophylaxis in elderly medically ill patients Source: Eur Respir J 2017; 49(1): 1601887; DOI: 10.1183/13993003.01887-2016 Year: 2017 Venous thrombo-embolism prophylaxis Source: Annual Congress 2009 - PG18 Practical clinical lessons in pulmonary vascular medicine: a case-based approach Year: 2009